Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [21] Chemotherapy-related cognitive impairment and kidney dysfunction
    Simeoni, Mariadelina
    Mulholland, Michele M.
    Workeneh, Biruh T.
    Capasso, Anna
    Hafez, Gaye
    Liabeuf, Sophie
    Malyszko, Jolanta
    Mani, Laila-Yasmin
    Trevisani, Francesco
    De, Ananya
    Wagner, Carsten A.
    Massy, Ziad A.
    Unwin, Robert
    Capasso, Giovambattista
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : ii54 - ii63
  • [22] The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors
    Nagi B. Kumar
    Current Treatment Options in Oncology, 2021, 22
  • [23] Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment
    Myers, Jamie S.
    CHEMO FOG: CANCER CHEMOTHERAPY-RELATED COGNITIVE IMPARIMENT, 2010, 678 : 55 - 69
  • [24] 'A new normal with chemobrain': Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors
    Henderson, Fiona M. E.
    Cross, Ainslea J.
    Baraniak, Amy R.
    HEALTH PSYCHOLOGY OPEN, 2019, 6 (01)
  • [25] Subjective cognition and mood in persistent chemotherapy-related cognitive impairment
    Vega, Jennifer N.
    Albert, Kimberly M.
    Mayer, Ingrid A.
    Taylor, Warren D.
    Newhouse, Paul A.
    JOURNAL OF CANCER SURVIVORSHIP, 2022, 16 (03) : 614 - 623
  • [26] Subjective cognition and mood in persistent chemotherapy-related cognitive impairment
    Jennifer N. Vega
    Kimberly M. Albert
    Ingrid A. Mayer
    Warren D. Taylor
    Paul A. Newhouse
    Journal of Cancer Survivorship, 2022, 16 : 614 - 623
  • [27] Prevalence of cognitive impairment and associated factors in older people
    Campos, Ana Carolina Brunatto Falchetti
    Teixeira, Iara Goncalves
    Moraes, Nayara de Souza
    Cadorin, Isabela de Jesus
    Morelli, Patricia Mariotto
    Lidio, Adrielly Vargas
    Medeiros, Eduarda Behenck
    Garcez, Michelle Lima
    Keller, Gabriela Serafim
    Kucharska, Ewa
    da Rosa, Maria Ines
    Ceretta, Luciane Bisognin
    Quevedo, Joao
    Budni, Josiane
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 355 : 283 - 289
  • [28] Functional connectome biotypes of chemotherapy-related cognitive impairment
    Kesler, Shelli R.
    Petersen, Melissa L.
    Rao, Vikram
    Harrison, Rebecca A.
    Palesh, Oxana
    JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (04) : 483 - 493
  • [29] Non-pharmacological therapy options for chemotherapy-related cognitive impairment
    Piechowicz, Paulina
    Dunaj, Piotr
    Janota, Aleksandra
    Kolodziejczyk, Katarzyna
    Dzierzanowski, Tomasz
    MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2022, 14 (04): : 173 - 182
  • [30] A Drosophila model relevant to chemotherapy-related cognitive impairment
    Torre, Matthew
    Bukhari, Hassan
    Nithianandam, Vanitha
    Zanella, Camila A.
    Mata, Douglas A.
    Feany, Mel B.
    SCIENTIFIC REPORTS, 2023, 13 (01)